Table 4.
Site of Care (Inpatient). | Empiric Therapy for Presumed Bacterial Pneumonia |
Empiric Therapy for Presumed Atypical Pneumonia |
Empiric Therapy for Presumed Influenza Pneumonia |
|||||
---|---|---|---|---|---|---|---|---|
Antibiotic | Route | Regimen | Antibiotic | Route | Regimen | Antiviral | ||
Uncomplicated CAP. | Initial therapy | Ampicillin | IV | 200 mg/kg/day divided every 6 hr. | Azithromycin | IV/PO | Given as a single daily dose; 10 mg/kg on day 1; 5 mg/kg on days 2 to ss 5 | Oseltamivir |
Or Penicillin G | IV | 250,000-400,000 U/kg/day divided every 4–6h | ||||||
Alternative | *Amoxicillin clavulanate | IV | 90 mg/kg/day divided every 8 hr. | Clarithromycin | PO | 15 mg/kg/day in 2 doses for 7–14 days. | ||
Or *Cefuroxime | IV | 150 mg/kg/day divided every 8 hr. | Or Erythromycin | IV/PO | 40mg/kg/day in 4 doses | |||
Complicated CAP. | Ceftriaxone | IV | 75mg/kg/day every 24 hr. | Same Empiric Therapy for Presumed Atypical Pneumonia in Uncomplicated Pneumonia. | ||||
**Clindamycin | IV | 40mg/kg/day divided every q8h | ||||||
Or**Vancomycin | IV | 60mg/kg/day divided every q8h |
Doses was adapted from 2017 Nelson's Pediatric Antimicrobial Therapy, 23rd Ed.
*Consider in children whom not completing Haemophilus influenzae type b (Hib) vaccines series (three doses).
** Consider if infection suspected due to community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) especially in cases of Necrotizing pneumonia, Sepsis, Concurrent skin infection due to MRSA, and/or Previous MRSA colonization. IV Intravenously; PO Orally.